Transient transfection (70-80 efficiency and 75% viability) of a DLBCL-MS cell line with the DN-IκBαM leads to the induction of IκBα protein level while suppressing constitutive NF-κB activation (Fig. 5A). The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.